The Institutional Review Board (IRB) of EORTC Headquarters is responsible for safeguarding the rights and welfare of subjects participating in clinical trials supported by the Headquarters. In particular, the IRB is responsible for protecting the privacy and confidentiality of the individuals’ data. The IRB is responsible for the validation of the document templates for informed consent and patient information sheets. All institutions and investigators submitting data to the Headquarters agree to abide by the decisions of the IRB regarding data collection, transfer, storage, release, retention, and disposition, as these pertain to individual patient privacy and confidentiality. The IRB also reviews potential conflicts of interest reported to the Headquarters.
In addition, the EORTC IRB oversees the clinical trials performed with the United States of America cooperative groups / National Cancer Institute under the Federalwide Agreement (FWA).
Chair: A. Negrouk, Brussels (BE)
F. Crawley, Leuven (BE)
C. de Balincourt, Brussels (BE)
C. Fortpied, Brussels (BE)
J. Geissler, Riemerling (DE)
J. Otten, Brussels (BE)
P. Ruyskart, Brussels (BE)